BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9699517)

  • 1. CCG1/TAF(II)250 regulates epidermal growth factor receptor gene transcription in cell cycle mutant ts13.
    Vargas GA; Isas JM; Fantino E; Gargus JJ; Haigler HT
    J Cell Physiol; 1998 Sep; 176(3):642-7. PubMed ID: 9699517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature.
    Suzuki-Yagawa Y; Guermah M; Roeder RG
    Mol Cell Biol; 1997 Jun; 17(6):3284-94. PubMed ID: 9154827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of transcription of p21 and cyclin D1 conferred by TAF(II)250.
    Rushton JJ; Steinman RA; Robbins PD
    Cell Growth Differ; 1997 Oct; 8(10):1099-104. PubMed ID: 9342188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAF(II)250 mutation.
    Sekiguchi T; Nishimoto T; Hunter T
    Oncogene; 1999 Mar; 18(10):1797-806. PubMed ID: 10086334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivation mediated by B-Myb is dependent on TAF(II)250.
    Bartusel T; Klempnauer KH
    Oncogene; 2003 May; 22(19):2932-41. PubMed ID: 12771944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus 1 late gene expression is preferentially inhibited during infection of the TAF250 mutant ts13 cell line.
    Dhar S; Weir JP
    Virology; 2000 Apr; 270(1):190-200. PubMed ID: 10772991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression.
    Dunphy EL; Johnson T; Auerbach SS; Wang EH
    Mol Cell Biol; 2000 Feb; 20(4):1134-9. PubMed ID: 10648598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.
    Adnane J; Shao Z; Robbins PD
    Oncogene; 1999 Jan; 18(1):239-47. PubMed ID: 9926939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins.
    Wang EH; Zou S; Tjian R
    Genes Dev; 1997 Oct; 11(20):2658-69. PubMed ID: 9334328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250.
    Wang EH; Tjian R
    Science; 1994 Feb; 263(5148):811-4. PubMed ID: 8303298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of human TAFII250: a TBP-associated factor implicated in cell-cycle regulation.
    Ruppert S; Wang EH; Tjian R
    Nature; 1993 Mar; 362(6416):175-9. PubMed ID: 7680771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimum essential region of CCG1/TAFII250 required for complementing the temperature-sensitive cell cycle mutants, tsBN462 and ts13 cells, of hamster BHK21 cells.
    Noguchi E; Sekiguchi T; Nohiro Y; Hayashida T; Hirose E; Hayashi N; Nishimoto T
    Somat Cell Mol Genet; 1994 Nov; 20(6):505-13. PubMed ID: 7892648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes.
    O'Brien T; Tjian R
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2456-61. PubMed ID: 10716982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAF(II)250-independent transcription can be conferred on a TAF(II)250-dependent basal promoter by upstream activators.
    Weissman JD; Howcroft TK; Singer DS
    J Biol Chem; 2000 Apr; 275(14):10160-7. PubMed ID: 10744699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1.
    Hisatake K; Hasegawa S; Takada R; Nakatani Y; Horikoshi M; Roeder RG
    Nature; 1993 Mar; 362(6416):179-81. PubMed ID: 8450888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.
    Wasylyk C; Wasylyk B
    Mol Cell Biol; 2000 Aug; 20(15):5554-70. PubMed ID: 10891494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAF(II)170 interacts with the concave surface of TATA-binding protein to inhibit its DNA binding activity.
    Pereira LA; van der Knaap JA; van den Boom V; van den Heuvel FA; Timmers HT
    Mol Cell Biol; 2001 Nov; 21(21):7523-34. PubMed ID: 11585931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250-TAF(II)150 complex recognizes the initiator.
    Chalkley GE; Verrijzer CP
    EMBO J; 1999 Sep; 18(17):4835-45. PubMed ID: 10469661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the myb gene product on expression of the PCNA gene in fibroblasts.
    Travali S; Ferber A; Reiss K; Sell C; Koniecki J; Calabretta B; Baserga R
    Oncogene; 1991 Jun; 6(6):887-94. PubMed ID: 1712444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250.
    Shao Z; Ruppert S; Robbins PD
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3115-9. PubMed ID: 7724524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.